OTC · STSN
Stemsation International, Inc.
$0.01$0.00 (0.0%)
Stemsation International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.41% below the high.
Loading market information…
OTC · SKYI · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Sky Century Investment, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sky Century Investment, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sky Century Investment, Inc. is engaged in the sale of cannabidiol (CBD) items crafted with pharmaceutical-grade components. In addition to its product line, the firm offers an array of digital services such as marketing strategy, meticulous planning, search engine optimization (SEO), detailed analytics, and insightful reporting. Moreover, it provides bespoke content and website development, alongside mail marketing campaigns, specifically aimed at companies involved in the creation of CBD goods. Established in 2012, Sky Century's headquarters are situated in Las Vegas, Nevada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Stemsation International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.41% below the high.
$0.01+$0.00 (+6.94%)
Sibannac, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.81% below the high.
$0.00$0.00 (0.0%)
TransGlobal Assets Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.01$0.00 (0.0%)
Maple Leaf Green World Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.86% below the high.
$0.00$0.00 (0.0%)
CuraScientific Corp: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Levitee Labs Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Industry Source Consulting, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.0% below the high.
$0.00$0.00 (0.0%)
Global Hemp Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.98% below the high.
